Browse by Sets
Number of items at this level: 2. Fontrier, Anna-Maria (2023) Entry to market of new medicines and medicines treating rare diseases: issues arising from value assessment processes in the European Union, the United Kingdom and Canada. PhD thesis, London School of Economics and Political Science. Efthymiadou, Anastasia Olga (2022) The role of “Managed Entry Agreements” in managing the market entry of new, high-cost, cancer medicines. The determinants and the impact of agreements implemented in Australia, England, Scotland and Sweden, as part of Health Technology Assessment processes. PhD thesis, London School of Economics and Political Science. |